{"name":"Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","slug":"immune-design-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOeHdvMVI2b1NueTdDYXYxMnFrcjhaWVhfMTdwX05ZaVctUmNLSXczbmQzU1pFeWZjN3RQRVh4UnJyOGdaS0VSX3Fsak0wTEpTdlQ4YVNUS0FWOFJxUjFxbTZJbms1X1lwV3R1aUY5U2tWQXRuWFJKX1FIeWppeHNodXVMZmpyOVRSN1ZCV0RMZEdQNnBVc2w5RGdUS2Q0NkhKTWFpMDlUc0xGMU1taGJ6VWpBVHQ1LUhmcVU4b0xkWWJsaG51MG9Z?oc=5","date":"2026-04-01","type":"regulatory","source":"IndexBox","summary":"Microneedle Patch Influenza Vaccine Delivery Market Driven by Pandemic Preparedness Demand to 2035 - IndexBox","headline":"Microneedle Patch Influenza Vaccine Delivery Market Driven by Pandemic Preparedness Demand to 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQVV9oSG81cWhuY1EyblVZbVU0eUZxWHZJY0RrS2hHMkduNG40R1JlVXBaLVlFYTUtTl9qU19oZ1RmWU9hR3MtbWFKNUtNWDFzM2E5YkJ5N09qYXlwdWxRWE5rb3ppUFdNYzRwNWNwM2lKRGFnOFgwajgxdlBrSFdjMjhVNXZFQXVMeTB0QnBWWGg4N1IxRXZLWGQzODExY2NTZUhiZ2dseHNST0RYbTI0SHhWUnI0MTBtRDBidVItR2dBZw?oc=5","date":"2026-03-31","type":"pipeline","source":"Reuters","summary":"Infinimmune, Merck enter into antibody discovery pact - Reuters","headline":"Infinimmune, Merck enter into antibody discovery pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQMlRndG1uMFV3ZjNsUHZabEppR2NRSVBHdXAyMUt3TjBxcVhQVThwQ0dJTUpJRGlReTN5SmdDTXFacEVNUklTTlRYaGdvS0R3ZC1wMjFHVGNkRVozVkxCNmVhRHJuZjYxdWxFSTg3OUlXOEpubWZhb0swOWp0UEhwaWlwd3ZpUXZzYnpOQUl2eUNMZlFRYW5ieUJMT2U5cUMzMHNGcg?oc=5","date":"2025-12-03","type":"trial","source":"Vaccine Advisor","summary":"V116 Elicits Robust Immune Responses in At-Risk Adults in Phase 3 Trial - Vaccine Advisor","headline":"V116 Elicits Robust Immune Responses in At-Risk Adults in Phase 3 Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1HemZETzExNjhQazVrZXY1RGFrVUEwbEw4QnhMMWRUdmMxNjBGNzRFQUtsR3hVQks2dmdNZVlCcTJ2Wm53VFdKcHJybFJQYWpBTlMyalphLW11SUowMW5URGxiYmk2Mzg1R3VXQXBHVXBUd1BvYXo0cmo4NTlCQdIBgwFBVV95cUxOdjV1YnlXTXNJNFZvRjRWWlJZbnRHZjdUZUJrckJYb1N6X1lQeEh0WjhUMnpjX0VfWERCT1ZxZXpWMTBYbEtwbFk1cFhyS1BIcUtaWHZsVFU0ZVhlUFJCV3cyakF0RmYxemRrZGxsRzR1aEdPUG9vZ1ZDUmRJd0plekI0QQ?oc=5","date":"2025-11-14","type":"deal","source":"CNBC","summary":"Merck bets on flu prevention with $9.2 billion deal for Cidara Therapeutics - CNBC","headline":"Merck bets on flu prevention with $9.2 billion deal for Cidara Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxQWEJSbER1alc5NnJEZDZLVXNPeF92SDNvUk1lZXRGTkNNVHMzM2VQVzBHQ0VXX3pKcVhObGR1cHJlMngtMFZ3end1UFdkYUdBMW9vVVNfUUJfZjUwZ255d1VldXd4S3pEYWRScWhpcEpwVE1qeG5Pa3ExT1pKSF8xd2xZS0NvYjJjQ3ptUGRXQzBOaXJWcURvLTREZ0ttajNyUHdMOHZIQURQeGlJWF82WHdkNnE2dFcxMXZzQnUxWkIzNFNKeUVXd2JrT1pRb2tqX1d0ajRCRnhBMEU0cFhjdE5IUmVkLUFUdGk0eWpnQnU0cTFSUVpwSVJUazFTU3U2ZEtWVWh6WFdOek5nckhxbWFMemVtLUk?oc=5","date":"2025-10-06","type":"trial","source":"BioSpace","summary":"Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases - BioSpace","headline":"Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Me","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFBBeWgyR1RtQnUzT3FsbEFCSlA5U1ZuMFNNSzdmSlRZXzlIaUptWkZXNy1XSmh4a1F6WkdWM2dxS2I0bER5YjZLcU44dDNoeTd5Vm14ZF80V1RUdTJJLUZwTlc5NngxSFE4UUVsV01Lb1JrWUFz?oc=5","date":"2025-01-13","type":"deal","source":"Fierce Pharma","summary":"The top 10 biopharma M&A deals of 2024 - Fierce Pharma","headline":"The top 10 biopharma M&A deals of 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTFBONEttRGE3V2RoajRCMDFVU2ZadmM4TGh2NkxDRnhEMW1Ldkd1ckdjTVk2MnRZZzhmT1QwVjRuTVlkS0Fra1A3UF9oNkRTN0FWeU9QRlpqLTVzcV9ZQ0JlbzRlWnZJRUtVU2RFeVppaTdLYzg?oc=5","date":"2024-09-27","type":"pipeline","source":"media.market.us","summary":"Top 10 Breast Cancer Treatment Providers | Provides Best Solutions - media.market.us","headline":"Top 10 Breast Cancer Treatment Providers | Provides Best Solutions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE9MSXlPN2hEa1RVdTlXYmQydEtoVks0UkRHRWRQY0pQdXN5X0gwOEpoYkRzdXA1TE9lS2VTbDdFVkhVSzZuMmZ2dDB3QVJSenotblB4LWw2eUhGOFVpbGtoSEZ1U05xSG9nQ1hVVFl3aFjSAXZBVV95cUxNYjgwVXotVjVpNE1nNmRXNmVnQVU4aGtZNUNjSG9qcXM0RENnQU1mNHUtMmlWclVlTjdZVlh6eS0ybWhMSG9HWnhKaXZxYTNEbU5nM01oaFBnR2k1d3d3UHptN3Jad0tBQlF5WDhFQjl6WmdHY3BB?oc=5","date":"2024-04-25","type":"earnings","source":"CNBC","summary":"Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales - CNBC","headline":"Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOb29waWQ5NXlZQ015a1o1bTJwOURxbWZHU0daSnpZVGZBaVVyM0ptQ0ZFRDh1NUNWZV8takhDMTJDdTM2V2ZVSm84ekI5cTh6dmtFdklmWHFVVlY0UEVEam9kMDgxZ0pBbjhqU2NLLW5DbTBYcXc1OHlQNnJ5WmdscWdFekJ6OUhZR21PWWJOdFowUVphVDJLN2QtVGdPZGtsZTlrSjVtUy1iZmRTVlA1T19vdVd0VzczRGxKMEVGSXBFMkV1YjBTV21CMFN5TDZYUWNCeTZ4S2d4TEpCYVhDZklLcw?oc=5","date":"2022-12-02","type":"patent","source":"Reuters","summary":"Focus: Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot - Reuters","headline":"Focus: Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1TaDN4bWNLRVdpSFV4U1FoZi1UZkYxak83VjZFV3NlZVFMVzNsb280R29iREh1TEp5MS1WVGpvQlZyWXhkV2NRU1Z4Vk8tSTdFdmpLdmo3MGtyVUljTDltR2hGLUdDckxXNnc?oc=5","date":"2022-07-06","type":"pipeline","source":"Wiley Online Library","summary":"Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826 - Wiley Online Library","headline":"Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results f","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiOkFVX3lxTE9xUnktMklHVURZci1jbkxlOUlJWXAwd0JFLXItcENtRDJlM3dINVJVZkV0S3BmeFVwcGc?oc=5","date":"2006-03-15","type":"pipeline","source":"Merck","summary":"Merck | Home - Merck","headline":"Merck | Home","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}